Baker Bros. Advisors (GP) LLC

Related Filers (40)

Ownership (465)

4
Wednesday, 1/3/2024
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/20/2023
Neurogene Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/18/2023
Seagen Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/15/2023
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/14/2023
MADRIGAL PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/14/2023
MADRIGAL PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2023
Prelude Therapeutics Inc: Statement of changes in beneficial ownership of securities
4
Friday, 11/24/2023
BELLICUM PHARMACEUTICALS, INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/21/2023
MADRIGAL PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/21/2023
MADRIGAL PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/15/2023
MADRIGAL PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/15/2023
MADRIGAL PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/14/2023
BeiGene, Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 10/23/2023
Atreca, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/10/2023
Neoleukin Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/5/2023
MADRIGAL PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/17/2023
Neoleukin Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/28/2023
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/21/2023
Prelude Therapeutics Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
BeiGene, Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
MADRIGAL PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/20/2023
MADRIGAL PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
4
Friday, 6/16/2023
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
TScan Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Talis Biomedical Corp: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Neoleukin Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/8/2023
Kiniksa Pharmaceuticals, Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
ACADIA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
TScan Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Seagen Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/24/2023
Prelude Therapeutics Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/24/2023
ACADIA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Friday, 5/5/2023
BELLICUM PHARMACEUTICALS, INC: Initial statement of beneficial ownership of securities
4
Wednesday, 5/3/2023
Seagen Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/6/2023
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2023
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2023
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/15/2023
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2023
ACADIA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/4/2022
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/5/2022
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Thursday, 6/30/2022
Kiniksa Pharmaceuticals, Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
BeiGene, Ltd.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/22/2022
Prelude Therapeutics Inc: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
DBV Technologies S.A.: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
Talis Biomedical Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2022
ACADIA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
Entrada Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
TScan Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/24/2022
Entrada Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/18/2022
Entrada Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/18/2022
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/17/2022
Seagen Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/16/2022
Neoleukin Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/12/2022
TScan Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/5/2022
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/15/2022
IGM Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/10/2022
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Thursday, 3/10/2022
Seagen Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/14/2022
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Monday, 1/31/2022
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Friday, 12/17/2021
INCYTE CORP: Statement of changes in beneficial ownership of securities
3
Thursday, 12/16/2021
Entrada Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/2/2021
Seagen Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/19/2021
Talis Biomedical Corp: Statement of changes in beneficial ownership of securities
4
Monday, 10/4/2021
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Friday, 10/1/2021
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/17/2021
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/9/2021
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/19/2021
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/13/2021
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/22/2021
TScan Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/15/2021
TScan Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 7/2/2021
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Thursday, 7/1/2021
Kiniksa Pharmaceuticals, Ltd.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Kodiak Sciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/24/2021
ACADIA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/22/2021
Prelude Therapeutics Inc: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
BeiGene, Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/10/2021
Aeglea BioTherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/28/2021
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
INCYTE CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Seagen Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/13/2021
Neoleukin Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
Show More